LoL – Yellen chickens out of hike interest rate as expected. Indeed, one FOMC member appears to be expecting negative rates. Just confirms that the Fed has no idea how to get the patient off the hopium. This party is going to have to carry on until we finally get a currency collapse. With […]
Continue reading
Well that’s okay, according to a recent survey by Bloomberg, most economists don’t think the next recession will be until 2018. As most of these are employed by banks with a vested interest to pump shares, this is most convenient, at least on two fronts. Firstly, the very low risk of an early recession is […]
Continue reading
Will she or won’t she? It seems with Fed interest rate policy remaining the only game in town, strategists are stuck with trying to second guess Yellen’s next move at the forthcoming FOMC on 16-17 September. Of course we’ve been here before and we can look at all the evidence and data under the sun […]
Continue reading
In a reversal of what happened in Valens’ day, the migrant flow is now going north from the Danube towards Germania rather than south, although there is a new empire that is to be shaken by such a move and that is no longer ruled from the south. Having wagged her imperial finger at the […]
Continue reading
For more see: www.growthrater.com Having adopted a “shape for growth motto†for 2015, GfK is struggling to deliver, with its core syndicated electronic research business hit hard in Q2 from the backwash from weakening Chinese demand. While the group is doggedly maintaining its full year 2015 guidance to deliver growth in organic revenues and […]
Continue reading
For more see – https://www.growthrater.com/growthrater/#/summary Last trading report – IMS to end July 2015: The pill investors are being asked to swallow is a new incentive scheme that could reward the CEO with up to 7.5m new shares (via nil priced options) over the next 3 years dependent on a TSR exceeding +8% […]
Continue reading
Pearson is pricing in a +3.9% CAGR growth rating but has delivered only +1% organic revenue growth in H1 FY15. Deferred revenues however were up +3% organic at end H1, which if translated into similar improvements in H2 organic revenue growth would put the group on course to perhaps delivering +4-5% for FY16 and therefore […]
Continue reading
Markets often distinguish growth from value, but for an equity, growth defines value. For most stocks, this can be seen by the close relationship between the organic revenue growth being delivered by a company and the implied growth rating being discounted by the share’s operating FCF yield. A problem however arises when trying to price […]
Continue reading